SZEB supply drug impurity of Tofacitinib
Time:2023-02-17
Views:264
Tofacitinib is FDA approved for the treatment of moderate to severe rheumatoid arthritis (RA), psoriatic arthritis (PA), ulcerative colitis (UC), and polyarticular course juvenile idiopathic arthritis (pcJIA). It is a second-generation selective Janus kinase (JAK) inhibitor targeting the JAK1 enzyme.
SZEB provide the impurities of Tofacitinib -related impurities,Discover all our products through our official website (https://www.ex-biotech.com/), and get in touch if you have any questions about how we can help support your work. Email:sale@ex-biotech.com.
The following are some of the impurities of Tofacitinib:
.jpg)
Wechat
Jolin
Yuzhu Lin
Ciel Wong
whatsapp